ストックスクリーナーアプリを入手
33.21
1.00%
0.33
アフターアワーズ：
33.21
前日終値:
$32.88
開ける：
$33.02
24時間の取引高:
427.06K
Relative Volume:
1.10
時価総額：
$1.05B
収益：
$566.77M
当期純損益:
$48.16M
株価収益率:
27.91
EPS:
1.19
ネットキャッシュフロー:
$274.29M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-6.77%
6か月 パフォーマンス:
+22.91%
1年 パフォーマンス:
-15.58%
1日の値動き範囲:
$32.43
$33.55
1週間の範囲:
$31.26
$33.55
52週間の値動き範囲:
$23.23
$39.95
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
名前
Collegium Pharmaceutical Inc
セクター
電話
781-713-3699
住所
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
COLL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
33.21 | 1.01B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
143.26 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.88 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.20 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.63 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
432.69 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | アップグレード | Needham | Hold → Buy |
| 2024-07-30 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | アップグレード | Jefferies | Hold → Buy |
| 2024-05-10 | ダウングレード | Needham | Buy → Hold |
| 2024-05-10 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | ダウングレード | Jefferies | Buy → Hold |
| 2023-08-25 | 繰り返されました | Needham | Buy |
| 2023-05-02 | 再開されました | Jefferies | Buy |
| 2022-08-08 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-07-14 | 開始されました | BWS Financial | Sell |
| 2020-05-27 | 開始されました | Guggenheim | Neutral |
| 2020-02-19 | 再開されました | Jefferies | Buy |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-03 | 再開されました | H.C. Wainwright | Buy |
| 2019-04-12 | 再開されました | Janney | Buy |
| 2019-03-20 | 開始されました | SunTrust | Hold |
| 2019-01-16 | 繰り返されました | Needham | Buy |
| 2018-03-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-02-07 | 繰り返されました | Needham | Buy |
| 2017-12-05 | 繰り返されました | Needham | Buy |
| 2017-09-11 | 開始されました | H.C. Wainwright | Buy |
| 2017-05-11 | 繰り返されました | Needham | Buy |
| 2016-09-13 | 開始されました | Gabelli & Co | Buy |
| 2015-06-01 | 開始されました | Jefferies | Buy |
| 2015-06-01 | 開始されました | Needham | Buy |
| 2015-06-01 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Collegium Pharmaceutical Inc (COLL) 最新ニュース
Why retail investors pile into Collegium Pharmaceutical Inc. stock2025 Investor Takeaways & High Accuracy Swing Entry Alerts - newser.com
How Collegium Pharmaceutical Inc. stock performs in rate cut cyclesBear Alert & Risk Adjusted Buy/Sell Alerts - newser.com
Will Collegium Pharmaceutical Inc. (354) stock sustain dividend payoutsM&A Rumor & High Conviction Trade Alerts - newser.com
Collegium Pharmaceutical Inc. Rings the Opening Bell - Nasdaq
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing - Sahm
Strategies to average down on Collegium Pharmaceutical Inc.July 2025 Fed Impact & Community Shared Stock Ideas - newser.com
How Collegium Pharmaceutical Inc. (354) stock compares with tech leadersPortfolio Value Summary & Weekly Market Pulse Updates - newser.com
Will Collegium Pharmaceutical Inc. stock gain from strong economy2025 Major Catalysts & Pattern Based Trade Signal System - newser.com
Applying sector rotation models to Collegium Pharmaceutical Inc.IPO Watch & Daily Profit Maximizing Tips - newser.com
Is Collegium Pharmaceutical Inc. stock a top pick in earnings seasonWeekly Market Report & Low Risk Entry Point Guides - newser.com
How interest rate cuts could boost Collegium Pharmaceutical Inc. stockGlobal Markets & High Accuracy Buy Signal Tips - newser.com
10-Year Anniversary: Collegium to Ring Nasdaq Bell Oct. 14, 2025; Highlights Jornay PM ADHD growth - Stock Titan
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates - sharewise.com
Collegium Pharmaceutical Experiences Revision in Its Stock Evaluation Amidst Market Dynamics - Markets Mojo
UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know - Yahoo Finance
Collegium Pharmaceutical, Inc. (COLL): A Bull Case Theory - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Receives "Hold (C)" Rating from Weiss Ratings - MarketBeat
Pattern recognition hints at Collegium Pharmaceutical Inc. upsideJobs Report & Free Technical Pattern Based Buy Signals - newser.com
Oversold Conditions For Collegium Pharmaceutical (COLL) - Nasdaq
Chronic Lower Back Pain Market Projected to Grow by 2034 | Eli Lilly, Collegium Pharmaceutical, Purdue Pharma, BioDelivery Sciences, Camurus, Braeburn, Scilex Holding, Mesoblast, AnGes MG, Kolon Life - Barchart.com
Can Collegium Pharmaceutical Inc. rally from current levelsPortfolio Gains Summary & Daily Price Action Insights - newser.com
Is Collegium Pharmaceutical Inc. (354) stock inflation resilientJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $42.33 Average Price Target from Brokerages - Defense World
Will Collegium Pharmaceutical Inc. bounce back from current supportWeekly Loss Report & Verified Momentum Stock Ideas - newser.com
Historical volatility pattern of Collegium Pharmaceutical Inc. visualized2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Long term hold vs stop loss in Collegium Pharmaceutical Inc.Weekly Risk Summary & AI Powered Market Trend Analysis - newser.com
GAMMA Investing LLC Raises Stake in Collegium Pharmaceutical, Inc. $COLL - Defense World
What drives Collegium Pharmaceutical Inc 354 stock priceEarnings Per Share Trends & High Profit Market Tips - earlytimes.in
Does Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Create Value For Shareholders? - Yahoo Finance
Collegium Pharmaceutical Inc (COLL) 財務データ
収益
当期純利益
現金流量
EPS
0.05%
5.75%
大文字化:
|
ボリューム (24 時間):